Haining Huang

Company: Cytimm Therapeutics

Job title: CSO

Seminars:

Chemically Modifying IL-2 to Optimize Delivery to Tregs for Sustained Responses 4:00 pm

Overview of PEGylated IL2v to enhance activation of Tregs with high specificity and maintain stability Highlighting preclinical data to predict clinical efficacy of PEGylated IL2v Overcoming the challenges to translate from preclinical models to humansRead more

day: Day One | Track B | Afternoon